InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Voliotis Dimitris, Vice-Président Senior, Développement clinique. Director active across 1 companies, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 3 reports have been recorded. The latest transaction was disclosed on 10 February 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
010,329 shares0
Common Stock
SEC:0001725160-22-000035:0·
€157,74810,000 shares@ €15.77480.055% mcap100.0% of flow
Common Stock
SEC:0001725160-22-000015·
€157,74810,000 shares@ €15.77480.055% mcap50.0% of flow
Common Stock
SEC:0001725160-22-000015:0·
3 of 3 declarations
About Voliotis Dimitris
Voliotis Dimitris is the Senior Vice President, Clinical Development at Zentalis Pharmaceuticals, Inc. He oversees clinical development programs and ensures compliance with regulations. His expertise in the pharmaceutical field is essential for the success of clinical trials and the development of new treatments. He plays a key role in the company's research and development strategy.
